{
    "contributors": null,
    "coordinates": null,
    "created_at": "Wed Oct 28 22:09:09 +0000 2015",
    "entities": {
        "hashtags": [],
        "symbols": [],
        "urls": [],
        "user_mentions": [
            {
                "id": 309728693,
                "id_str": "309728693",
                "indices": [
                    0,
                    15
                ],
                "name": "Gilead Sciences",
                "screen_name": "GileadSciences"
            }
        ]
    },
    "favorite_count": 0,
    "favorited": false,
    "geo": null,
    "id": 659492124283437056,
    "id_str": "659492124283437056",
    "in_reply_to_screen_name": "GileadSciences",
    "in_reply_to_status_id": null,
    "in_reply_to_status_id_str": null,
    "in_reply_to_user_id": 309728693,
    "in_reply_to_user_id_str": "309728693",
    "is_quote_status": false,
    "lang": "en",
    "metadata": {
        "iso_language_code": "en",
        "result_type": "recent"
    },
    "place": null,
    "retweet_count": 0,
    "retweeted": false,
    "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>",
    "text": "@GileadSciences If Sovaldi/Velpatasvir, is approved 1pill, 1x day for GT 1-6= Major medical breakthrough that is WAY under appreciated",
    "truncated": false,
    "user": {
        "contributors_enabled": false,
        "created_at": "Wed Aug 08 07:10:29 +0000 2012",
        "default_profile": true,
        "default_profile_image": false,
        "description": "(Pharm.D.), GLG Council Member (Oncology, Liver Diseases, & Pharmacogenomics), Equities & Options",
        "entities": {
            "description": {
                "urls": []
            },
            "url": {
                "urls": [
                    {
                        "display_url": "alphabiopharmaadvisers.com",
                        "expanded_url": "http://alphabiopharmaadvisers.com",
                        "indices": [
                            0,
                            22
                        ],
                        "url": "http://t.co/BXxcgHaope"
                    }
                ]
            }
        },
        "favourites_count": 5517,
        "follow_request_sent": false,
        "followers_count": 1601,
        "following": false,
        "friends_count": 553,
        "geo_enabled": false,
        "has_extended_profile": false,
        "id": 744650100,
        "id_str": "744650100",
        "is_translation_enabled": false,
        "is_translator": false,
        "lang": "en",
        "listed_count": 59,
        "location": "",
        "name": "Dr. Paul DeSantis",
        "notifications": false,
        "profile_background_color": "C0DEED",
        "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png",
        "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png",
        "profile_background_tile": false,
        "profile_banner_url": "https://pbs.twimg.com/profile_banners/744650100/1386554054",
        "profile_image_url": "http://pbs.twimg.com/profile_images/378800000848069477/0b876c0ab757cf4ddda22f68e6e01caf_normal.jpeg",
        "profile_image_url_https": "https://pbs.twimg.com/profile_images/378800000848069477/0b876c0ab757cf4ddda22f68e6e01caf_normal.jpeg",
        "profile_link_color": "0084B4",
        "profile_sidebar_border_color": "C0DEED",
        "profile_sidebar_fill_color": "DDEEF6",
        "profile_text_color": "333333",
        "profile_use_background_image": true,
        "protected": false,
        "screen_name": "DrPaulyDeSantis",
        "statuses_count": 15715,
        "time_zone": null,
        "url": "http://t.co/BXxcgHaope",
        "utc_offset": null,
        "verified": false
    }
}